
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX)
WebsitePrice
Market cap
Next catalystExpected 2H 2027pegtibatinase (TVT-058) — classical homocystinuria · Phase 3 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Approved
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Approved
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved / commercial
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved